These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 33595132)

  • 1. Effect of increased prolactin and psychosocial stress on erectile function.
    Fiala L; Lenz J; Sajdlova R
    Andrologia; 2021 May; 53(4):e14009. PubMed ID: 33595132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Erectile dysfunction in patients with first-episode psychosis.
    Gaber HD; El-Beeh KAM; Abd Al-Naser FAW; Hosny A
    Andrologia; 2020 Dec; 52(11):e13793. PubMed ID: 32833250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hyperprolactinemia and sexual activity of men--clinical aspect].
    Medraś M; Jankowska EA
    Pol Arch Med Wewn; 2004 Mar; 111(3):327-31. PubMed ID: 15230214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hormonal etiology in erectile dysfunction].
    Jabaloyas JM
    Arch Esp Urol; 2010 Oct; 63(8):621-7. PubMed ID: 20978293
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypothalamic-hypophyseal-testicular abnormalities and erectile dysfunction.
    Shah RS; Pardanani DS; Parulkar BG; Purohit SP; Bandivdekar AH; Sheth AR
    Arch Androl; 1988; 20(2):137-40. PubMed ID: 3134861
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Is routine hormonal measurement necessary in initial evaluation of men with erectile dysfunction?
    Acar D; Cayan S; Bozlu M; Akbay E
    Arch Androl; 2004; 50(4):247-53. PubMed ID: 15277002
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Erectile dysfunction secondary to hyperprolactinemia. Apropos of 13 cases].
    Abram F; Linke F; Kalfon A; Tchovelidze C; Chelbi N; Arvis G
    Prog Urol; 1998 Sep; 8(4):537-41. PubMed ID: 9834517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine contribution to the sexual dysfunction in patients with advanced chronic kidney disease and the role of hyperprolactinemia.
    Elbardisi H; Majzoub A; Daniel C; Al Ali F; Elesnawi M; Khalafalla K; Agarwal A; Henkel R; Alattar A; Al-Emadi I; Arafa M
    Andrologia; 2021 Sep; 53(8):e14135. PubMed ID: 34089536
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hyperprolactinemia and sexual function in men.
    Buvat J; Lemaire A; Buvat-Herbaut M; Fourlinnie JC; Racadot A; Fossati P
    Horm Res; 1985; 22(3):196-203. PubMed ID: 4054839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Male sexual functions in hyperprolactinemia].
    Gladkova AI
    Urol Nefrol (Mosk); 1987; (4):71-4. PubMed ID: 3660518
    [No Abstract]   [Full Text] [Related]  

  • 11. Severe erectile dysfunction is a marker for hyperprolactinemia.
    Johri AM; Heaton JP; Morales A
    Int J Impot Res; 2001 Jun; 13(3):176-82. PubMed ID: 11525317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Six months of treatment with cabergoline restores sexual potency in hyperprolactinemic males: an open longitudinal study monitoring nocturnal penile tumescence.
    De Rosa M; Zarrilli S; Vitale G; Di Somma C; Orio F; Tauchmanova' L; Lombardi G; Colao A
    J Clin Endocrinol Metab; 2004 Feb; 89(2):621-5. PubMed ID: 14764772
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experimental hyperprolactinemia in a rat model: alteration in centrally mediated neuroerectile mechanisms.
    Rehman J; Christ G; Alyskewycz M; Kerr E; Melman A
    Int J Impot Res; 2000 Feb; 12(1):23-32. PubMed ID: 10982309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endocrine screening in 1,022 men with erectile dysfunction: clinical significance and cost-effective strategy.
    Buvat J; Lemaire A
    J Urol; 1997 Nov; 158(5):1764-7. PubMed ID: 9334596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of daily intake of apomorphine SL in men affected by erectile dysfunction and mild hyperprolactinemia: a prospective, open-label, pilot study.
    Caruso S; Intelisano G; Farina M; DiMari L; Agnello C; Giammusso B
    Urology; 2003 Nov; 62(5):922-7. PubMed ID: 14624921
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autoeroticism, mental health, and organic disturbances in patients with erectile dysfunction.
    Corona G; Ricca V; Boddi V; Bandini E; Lotti F; Fisher AD; Sforza A; Forti G; Mannucci E; Maggi M
    J Sex Med; 2010 Jan; 7(1 Pt 1):182-91. PubMed ID: 19758284
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of prolactin on penile erection: a cross-sectional study.
    Xu ZH; Pan D; Liu TY; Yuan MZ; Zhang JY; Jiang S; Wang XS; Guan Y; Zhao ST
    Asian J Androl; 2019; 21(6):587-591. PubMed ID: 31044754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oral phosphodiesterase-5 inhibitors and hormonal treatments for erectile dysfunction: a systematic review and meta-analysis.
    Tsertsvadze A; Fink HA; Yazdi F; MacDonald R; Bella AJ; Ansari MT; Garritty C; Soares-Weiser K; Daniel R; Sampson M; Fox S; Moher D; Wilt TJ
    Ann Intern Med; 2009 Nov; 151(9):650-61. PubMed ID: 19884626
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The importance of hyperprolactinemia in impotence.
    Netto Júnior NR; Claro Jde A
    Rev Paul Med; 1993; 111(6):454-5. PubMed ID: 8052792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Independent Association of Erectile Dysfunction and Low Testosterone Levels With Life Dissatisfaction in Men With Chronic Spinal Cord Injury.
    D'Andrea S; Minaldi E; Castellini C; Cavallo F; Felzani G; Francavilla S; Francavilla F; Barbonetti A
    J Sex Med; 2020 May; 17(5):911-918. PubMed ID: 32089485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.